Skip to content

In vivo dermatofluoroscopy to optimize the algorithm for "intelligent measurement" of malignant melanomas.

In vivo dermatofluoroscopy to optimize the algorithm for "intelligent measurement" of malignant melanomas. - Magnosco

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028051
Enrollment
80
Registered
2022-02-08
Start date
2022-02-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43

Interventions

Group 1: Patients with suspected malignant melanoma are examined once before the planned surgical removal of a suspicious lesion. This involves photodocumentation and dermoscopic imaging of the suspic

Sponsors

Magnosco GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: at least 18 years old, skin lesion suspected to be malignant melanoma, planned histological analysis of skin lesion to be excised, skin type I–IV (Fitzpatrick), informed about the aims and the character of the study, written informed consent for the participation in the study, suspected lesion is not injured, not bleeding, not ulcerating and can be reached by the measurement device, Suspect can remain still for 30 minutes

Exclusion criteria

Exclusion criteria: minors, skin lesion not suspected to be malignant melanoma, breast feeding women or women with known pregnancy, skin type >IV (Fitzpatrick), injured, bleeding or ulcerating lesion, lesion can not be reached by the measurement device, subjects who cannot make decisions on their own, patients with tremor or inability to remain still for 30 min

Design outcomes

Primary

MeasureTime frame
At least the same measurement accuracy after application of the newly developed algorithm with reduced measurement time compared to the previously applied algorithm (non-inferiority).

Secondary

MeasureTime frame
An increased measurement accuracy after application of the newly developed algorithm with a shortened measurement time compared to the previously applied algorithm.

Countries

Germany

Contacts

Public ContactMartina Meinke

Charité – Universitätsmedizin Berlin,Department of Dermatology, Venerology and Allergology,Center of Experimental and Applied Cutaneous Physiology (CCP)

martina.meinke@charite.deFax: +49 30 450 518244

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026